SCOTTSDALE, ARIZONA -- (MARKET WIRE) -- October 20, 2006 -- Holmes Biopharma, Inc. (OTCBB: HLMB) announced today that its Clinical Pharmacology Division in Omaha, Nebraska, has commenced work on its first contract, a Phase 1 trial for rheumatoid arthritis patients.
